Clinical Trial Update: Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries [Phase 2, Phase 3]

View source ↗

Summary

This Stanford-initiated clinical trial is evaluating a targeted medical therapy for angina and nonobstructive coronary arteries in Phase 2/3 and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Microvascular Angina
• Myocardial Bridge of the Coronary Artery
• Vasospastic Angina

Snippet

Sponsor: Stanford University | Conditions: Angina Pectoris, Microvascular Angina | Phase 2, Phase 3 | Status: RECRUITING